Dow Down 0.25% Nasdaq Down 0.26%

Albany Molecular Research Inc. (AMRI)

-NasdaqGS
19.81 Down 0.06(0.30%) Aug 28, 4:00PM EDT
Prev Close:19.87
Open:19.85
Bid:N/A
Ask:22.18 x 200
1y Target Est:18.75
Beta:2.09
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:19.52 - 20.05
52wk Range:9.71 - 22.30
Volume:146,754
Avg Vol (3m):409,092
Market Cap:625.12M
P/E (ttm):65.38
EPS (ttm):0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AMRI

Comparison

Symbol% ChgMkt Cap
AMRIDown 0.30%625.12M
CVDUp 0.20%4.73B
QDown 0.70%7.17B

Key Statistics

Forward P/E (1 yr):17.23
P/S (ttm):2.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.91
Quarterly EPS Est (Sep-14) :0.17
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback